Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...

HHS Secretary Robert F. Kennedy Jr. has made clear that he would like to ban direct-to-consumer drug advertisements on ...

The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” ...

Zus Health, led by former athenahealth CEO Jonathan Bush, aims to create unified health records. Company has 60+ customers ...

GUBamy, AbbVie-licensed amylin drug from Gubra, shows 7.8% weight loss in Phase 1 trial, vs 2% weight gain with placebo after ...

Talkspace is using AI to make mini podcast episodes from patients’ therapy sessions. The “Talkcast” episodes are meant to be ...

Step back from the multitude of details that go into every big pharma pipeline, and you'll see the influence that ...

When the transatlantic startup AIRNA launched in 2023, it was already years behind other companies that were trying to bring ...

Eli Lilly's RNA drug solbinsiran reduced ApoB protein levels by 14.3% in Phase 2 cholesterol trial, competing with ...

Sanofi hires former GSK development head Chris Corsico as global R&D head, replacing Dietmar Berger who left for Gilead. Move ...

Vertex lost a legal battle against the federal government on Monday over its proposed fertility support program that would ...

The FDA overstepped its authority when it issued a rule last May to bring laboratory-developed tests under the agency’s ...